Eicosapentaenoic acid attenuates statin-induced ER stress and toxicity in myoblast

被引:17
作者
Ohta, Masahiko [1 ]
Kawano, Hiroyuki [1 ]
Notsu, Tatsuto [1 ]
Naba, Hiroyasu [1 ]
Imada, Kazunori [1 ]
机构
[1] Mochida Pharmaceut Co Ltd, Pharmaceut Res Ctr, Jimba, Gotemba 4128524, Japan
关键词
Statins; Myoblast; Toxicity; ER stress; EPA; COA REDUCTASE INHIBITORS; ENDOPLASMIC-RETICULUM STRESS; FATTY-ACIDS; DOCOSAHEXAENOIC ACID; SCAVENGER RECEPTOR; SIGNALING PATHWAY; INDUCED APOPTOSIS; L6; MYOBLASTS; MUSCLE-CELLS; SIMVASTATIN;
D O I
10.1016/j.bbrc.2012.06.111
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
We previously reported that eicosapentaenoic acid (EPA) improved statin-induced rhabdomyolysis in rats (Naba et al. [6]). In this study, we report for the first time direct improvement by EPA of statin-induced toxicity in cultured myoblasts and the mechanistic involvement of endoplasmic reticulum (ER) stress. Differentiated rhabdomyosarcoma cells (RD cells) were treated with statins and EPA for 1- 4 days. Statins induced various toxic changes in RD cells, and EPA attenuated all of these changes. Interestingly, statins increased mRNA expression of ER stress markers (KBP-1 and CHOP) and EPA attenuated both. Further, in a statin-induced rat model of rhabdomyolysis, these markers in skeletal muscle were significantly correlated with plasma CPK activity. In RD cells, statins also increased p-c-Jun protein content and caspase-3/7 activity, while 4-PBA, an ER stress attenuator, PPAR-delta agonist, and EPA attenuated them. These findings suggest that EPA attenuates statin-induced ER stress, JNK activation and toxicity in cultured myoblast cells, and that PPAR-delta may mechanically involved in the effects of EPA. (C) 2012 Elsevier Inc. All rights reserved.
引用
收藏
页码:301 / 307
页数:7
相关论文
共 39 条
[1]   Docosahexaenoic acid: A positive modulator of Akt signaling in neuronal survival [J].
Akbar, M ;
Calderon, F ;
Wen, ZM ;
Kim, HY .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2005, 102 (31) :10858-10863
[2]   Omega-3 fatty acids improve hepatic steatosis in a murine model:: Potential implications for the marginal steatotic liver donor [J].
Alwayn, IPJ ;
Andersson, C ;
Zauscher, B ;
Gura, K ;
Nosé, V ;
Puder, M .
TRANSPLANTATION, 2005, 79 (05) :606-608
[3]   Statin-induced myopathy: The two faces of Janus [J].
Arora, Rohit ;
Liebo, Max ;
Maldonado, Frank .
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS, 2006, 11 (02) :105-112
[4]   Statin-associated neuromyotoxicity [J].
Baker, SK ;
Tarnopolsky, MA .
DRUGS OF TODAY, 2005, 41 (04) :267-293
[5]   Direct vascular effects of HMG-CoA reductase inhibitors [J].
Bellosta, S ;
Bernini, F ;
Ferri, N ;
Quarato, P ;
Canavesi, M ;
Arnaboldi, L ;
Fumagalli, R ;
Paoletti, R ;
Corsini, A .
ATHEROSCLEROSIS, 1998, 137 :S101-S109
[6]   STUDIES ON THE EFFECT OF MEVINOLIN (LOVASTATIN) AND MEVASTATIN (COMPACTIN) ON THE FUSION OF L6 MYOBLASTS [J].
BELO, RS ;
JAMIESON, JC ;
WRIGHT, JA .
MOLECULAR AND CELLULAR BIOCHEMISTRY, 1993, 126 (02) :159-167
[7]   c-Jun N-terminal protein kinase signalling pathway mediates lovastatin-induced rat brain neuroblast apoptosis [J].
Cerezo-Guisado, Maria Isabel ;
Alvarez-Barrientos, Alberto ;
Argent, Ricardo ;
Jesus Garcia-Marin, Luis ;
Julia Bragado, Maria ;
Jesus Lorenzo, Maria .
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS, 2007, 1771 (02) :164-176
[8]  
Chang J Y, 2001, BMC Pharmacol, V1, P10, DOI 10.1186/1471-2210-1-10
[9]   Apoptosis induced by simvastatin in rat vascular smooth muscle cell through Ca2+-calpain and caspase-3 dependent pathway [J].
Cheng, G ;
Shan, J ;
Xu, G ;
Huang, JY ;
Ma, J ;
Ying, SQ ;
Zhu, LJ .
PHARMACOLOGICAL RESEARCH, 2003, 48 (06) :571-578
[10]   N-3 FATTY-ACIDS AND RENAL DISEASES [J].
DECATERINA, R ;
ENDRES, S ;
KRISTENSEN, SD ;
SCHMIDT, EB .
AMERICAN JOURNAL OF KIDNEY DISEASES, 1994, 24 (03) :397-415